The Cost of Waiting: Why Capital Planning Should Start Before You Need It
Most plaintiff firms do not think about capital until they need it. A major case requires significant expert costs. A lateral hire becomes available. Cash flow tightens while several large cases move toward trial. By the time these decisions become urgent, the available options are often limited.
One question deserves attention long before any of that happens: who will finance the firm's growth, and on what terms?
Rick Meadow confronted that question when he launched The Meadow Law Firm as one of Arizona's first plaintiff firms operating as an Alternative Business Structure. This license allows people outside the legal profession to invest in and partly own a law firm. Most states do not permit this. Arizona does, and the difference shaped what his firm could become.
While most plaintiff firms will never operate as an ABS, the underlying principle applies to every practice. Every source of capital comes with expectations attached, whether it arrives as a bank loan, an investor, or a funding partner. The terms attached to that capital end up shaping a firm as much as the people running it.
Capital Changes More Than Your Balance Sheet
Taking on capital is as much an exchange of influence as a financial transaction. A bank loan comes with covenants. An investor comes with reporting requirements or a seat at the table. A litigation funding partner comes with terms about case selection, timelines, or settlement thresholds. Each source shapes how decisions get made inside a firm and what the firm can afford.
Rick Meadow ran into this directly. Structuring his firm as an ABS meant giving a capital partner real influence over decisions that had once been his alone. That kind of scrutiny is rare, mostly because most attorneys never take on outside capital in the first place.
Not Every Dollar Is Worth Taking
When asked what he would do with hundreds of millions in funding, Rick Meadow's answer was direct. He does not know what he would do with 100 to 200 million dollars, and that uncertainty is exactly why he would not take it.
That is an unusual instinct in a market where more capital usually reads as more opportunity. But oversized funding creates its own problem. A capital partner who provides more than a firm can responsibly deploy is buying influence that the firm did not need to give away. That influence shows up later in case selection, settlement timing, and whose financial needs end up driving decisions that were supposed to be the firm's alone.
The Right Partner Matters More Than the Largest Check
Comparing the size of the check overlooks the things that actually determine whether a partnership works. Alignment matters: does the partner's incentive align with the firm's timeline, or does it pressure decisions toward a faster exit than the case warrants? Governance matters: who has the authority to walk away mid-case, and under what terms. Exit provisions matter most of all, since a partner who can leave when a case gets harder than expected can do more damage than the absence of funding ever could.
These concerns decide whether outside capital strengthens a firm's long-term strategy or quietly takes it over.
The Terms Come Before the Decision
Whether a firm is evaluating outside investment, litigation funding, an ownership transition, or long-term growth, the same principle applies: understand how the capital is structured before deciding whether to accept it. The funding decision is ultimately about incentives, control, and the future you are building.
If your firm is evaluating litigation funding, outside investment, attorney fee deferral, succession planning, or broader capital strategy, Mirena and Company works with plaintiff firms on exactly these issues and would be glad to continue the conversation.
Mirena Umizaj Dumas is the Founder and CEO of Mirena and Company.
